GLACIER: An open-label, randomized, multicenter study to assess the safety and tolerability of glatiramer acetate 40mg three-times weekly versus 20mg daily in patients with relapsing-remitting multiple sclerosis.
Wolinsky JS, Borresen ET, Dietrich DW, Wynn D, Sidi Y, Steinerman JR, Knappertz V, Kolodny S, GLACIER Study Group
Mult Scler Relat Disord. 2015 Jul; 4(4):370-6. PMID: 26195058.Abstract